Concepedia

Hua Guo

HG

16

Publications

1.2K

Citations

14

H-Index

2008

Active since

Affiliations

AbbVie (United States)(Current)

Albert Einstein College of Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Georgetown University

Inserm

Hua Guo is an author at AbbVie (United States) specializing in stroke, medicine, and neurology.

Top concepts

Publications per year

2008–2025

16

Publications

16

Atogepant for the Preventive Treatment of Migraine

Jessica Ailani, Richard B. Lipton, Peter J. Goadsby et al. · New England Journal of Medicine · 2021 · 287 citations · Full text

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams‐Herman, Samuel S. Engel, Elizabeth Round et al. · BMC Endocrine Disorders · 2010 · 254 citations · Full text

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

Juan Camilo Arjona Ferreira, Michel Marre, Nir Barzilai et al. · Diabetes Care · 2012 · 157 citations · Full text

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Nir Barzilai, Hua Guo, Erin Mahoney et al. · Current Medical Research and Opinion · 2011 · 128 citations

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

Patricia Pozo‐Rosich, Jessica Ailani, Messoud Ashina et al. · The Lancet · 2023 · 121 citations

, , +9

Rows per page

1–5 of 16